Explore the groundbreaking world of GLP-1 agonists in this 51-minute conference talk from The Aspen Institute. Delve into the history and evolution of these drugs since their 2005 approval for diabetes treatment. Discover their expanding applications in obesity management, cardiovascular health, and potential use for sleep apnea. Learn about ongoing research investigating their effects on drug, alcohol, and nicotine addictions. Examine the challenges surrounding these promising medications, including cost, insurance coverage, and long-term usage requirements. Engage in a thought-provoking discussion on the drugs' mechanisms, future possibilities, and the crucial issue of ensuring accessibility for those who need them most. Gain insights into the cutting-edge developments in medical science that could reshape treatment approaches for multiple health conditions in the 21st century.